IBDEI0KH ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10036,1,5,0)
 ;;=5^Osteoporosis
 ;;^UTILITY(U,$J,358.3,10036,2)
 ;;=Osteoporosis^87159
 ;;^UTILITY(U,$J,358.3,10037,0)
 ;;=626.5^^67^671^38
 ;;^UTILITY(U,$J,358.3,10037,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10037,1,4,0)
 ;;=4^626.5
 ;;^UTILITY(U,$J,358.3,10037,1,5,0)
 ;;=5^Ovulation Bleeding
 ;;^UTILITY(U,$J,358.3,10037,2)
 ;;=Ovulation Bleeding^270570
 ;;^UTILITY(U,$J,358.3,10038,0)
 ;;=625.2^^67^671^39
 ;;^UTILITY(U,$J,358.3,10038,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10038,1,4,0)
 ;;=4^625.2
 ;;^UTILITY(U,$J,358.3,10038,1,5,0)
 ;;=5^Ovulation Pain
 ;;^UTILITY(U,$J,358.3,10038,2)
 ;;=Ovulation Pain^265259
 ;;^UTILITY(U,$J,358.3,10039,0)
 ;;=614.9^^67^671^42
 ;;^UTILITY(U,$J,358.3,10039,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10039,1,4,0)
 ;;=4^614.9
 ;;^UTILITY(U,$J,358.3,10039,1,5,0)
 ;;=5^Pelvic inflammatory disease
 ;;^UTILITY(U,$J,358.3,10039,2)
 ;;=^3537
 ;;^UTILITY(U,$J,358.3,10040,0)
 ;;=789.30^^67^671^40
 ;;^UTILITY(U,$J,358.3,10040,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10040,1,4,0)
 ;;=4^789.30
 ;;^UTILITY(U,$J,358.3,10040,1,5,0)
 ;;=5^Pelvic Mass
 ;;^UTILITY(U,$J,358.3,10040,2)
 ;;=Pelvic Mass^917
 ;;^UTILITY(U,$J,358.3,10041,0)
 ;;=622.7^^67^671^44
 ;;^UTILITY(U,$J,358.3,10041,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10041,1,4,0)
 ;;=4^622.7
 ;;^UTILITY(U,$J,358.3,10041,1,5,0)
 ;;=5^Polyp of Cervix
 ;;^UTILITY(U,$J,358.3,10041,2)
 ;;=Polyp of Cervix^79612
 ;;^UTILITY(U,$J,358.3,10042,0)
 ;;=627.1^^67^671^45
 ;;^UTILITY(U,$J,358.3,10042,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10042,1,4,0)
 ;;=4^627.1
 ;;^UTILITY(U,$J,358.3,10042,1,5,0)
 ;;=5^Postmenopausal bleeding
 ;;^UTILITY(U,$J,358.3,10042,2)
 ;;=^97040
 ;;^UTILITY(U,$J,358.3,10043,0)
 ;;=V24.2^^67^671^46
 ;;^UTILITY(U,$J,358.3,10043,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10043,1,4,0)
 ;;=4^V24.2
 ;;^UTILITY(U,$J,358.3,10043,1,5,0)
 ;;=5^Postpartum
 ;;^UTILITY(U,$J,358.3,10043,2)
 ;;=Postpartum^114052
 ;;^UTILITY(U,$J,358.3,10044,0)
 ;;=V22.2^^67^671^47
 ;;^UTILITY(U,$J,358.3,10044,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10044,1,4,0)
 ;;=4^V22.2
 ;;^UTILITY(U,$J,358.3,10044,1,5,0)
 ;;=5^Pregnancy Status
 ;;^UTILITY(U,$J,358.3,10044,2)
 ;;=Pregnancy Status^97923
 ;;^UTILITY(U,$J,358.3,10045,0)
 ;;=627.0^^67^671^48
 ;;^UTILITY(U,$J,358.3,10045,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10045,1,4,0)
 ;;=4^627.0
 ;;^UTILITY(U,$J,358.3,10045,1,5,0)
 ;;=5^Premenopausal menorrhagia
 ;;^UTILITY(U,$J,358.3,10045,2)
 ;;=^270575
 ;;^UTILITY(U,$J,358.3,10046,0)
 ;;=625.4^^67^671^49
 ;;^UTILITY(U,$J,358.3,10046,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10046,1,4,0)
 ;;=4^625.4
 ;;^UTILITY(U,$J,358.3,10046,1,5,0)
 ;;=5^Premenstrual tension
 ;;^UTILITY(U,$J,358.3,10046,2)
 ;;=^98014
 ;;^UTILITY(U,$J,358.3,10047,0)
 ;;=302.70^^67^671^51
 ;;^UTILITY(U,$J,358.3,10047,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10047,1,4,0)
 ;;=4^302.70
 ;;^UTILITY(U,$J,358.3,10047,1,5,0)
 ;;=5^Sexual dysfunction, psychosexual
 ;;^UTILITY(U,$J,358.3,10047,2)
 ;;=^100647
 ;;^UTILITY(U,$J,358.3,10048,0)
 ;;=599.0^^67^671^55
 ;;^UTILITY(U,$J,358.3,10048,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10048,1,4,0)
 ;;=4^599.0
 ;;^UTILITY(U,$J,358.3,10048,1,5,0)
 ;;=5^Urinary Tract Infection
 ;;^UTILITY(U,$J,358.3,10048,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,10049,0)
 ;;=218.9^^67^671^56
 ;;^UTILITY(U,$J,358.3,10049,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10049,1,4,0)
 ;;=4^218.9
 ;;^UTILITY(U,$J,358.3,10049,1,5,0)
 ;;=5^Uterine Fibroids
 ;;^UTILITY(U,$J,358.3,10049,2)
 ;;=Uterine Fibroids^68944
